Until 2015, Stephan Walz was the Managing Director of Aristo, a pan-European company co-owned by the former Hexal founders. During his 14 years at the helm of Aristo, the company grew significantly, both organically and through a series of acquisitions, to become one of the leading pharmaceutical companies in Germany, both in generic and OTC products.
Born in Berlin, Stephan Walz holds a Dual Degree in Chemistry and Pharmacy from the Free University of Berlin (Freie Universität Berlin). His experience in the pharmaceutical industry began at Schering AG in 1990. He later occupied several positions at Lindopharm GmbH, before founding Aristo Pharma GmbH. At Aristo he specialised in integrating multiple companies, among them, Esparma GmbH and Medicamentos Internacionales, S.A. (Medinsa).
Lluís Pérez has a professional background expertise focused in the Corporate Finance Control and the Finance fields, having an extensive international experience in large multiple locations companies.
The professional career of Lluís has been developed for more than eight years as Group CFO in different Business Units of the second largest producer of steel in Europe, Celsa Group (in the UK, Scandinavia and Poland) and, being Group CFO of Goldcar (private equity owned) his last position.
He is an expert in the integration of subsidiaries, in coordinating multi-sites Finance departments, refinancings and in analyse feasibility of new investments and lead M&A processes.
Lluís holds a BS in Business Economics from the Universitat Autònoma de Barcelona and an E-MBA.
Dr Christoph Koch is the Corporate Director of Business Development & Licensing at NuPharm looking after the group’s product portfolio which includes both in- and out-licensing activities as well as growing NuPharm’s footprint through M&A activities.
Christoph joined NuPharm in August 2017, coming from DSM Sinochem Pharmaceuticals, where he has been building the B2B licensing of Drug Products.
Originally a scientist with a Ph.D. in Organic Chemistry from the University of Cologne, Christoph has more than 15 years’ industry experience having previously worked in leading BD roles for Heumann Pharma, the German subsidiary of Torrent Pharmaceuticals, and Helm in Hamburg.
Christoph has lived in Belgium, Germany and the Netherlands and is now based in Barcelona.
Burghard Burczyk has more than twenty years of leadership experience in international companies being an expert in successfully implementing strategic planning in purchasing, production, technology and supply chain.
He has a proven track record in product transfer and in procurement management within several pharmaceutical companies, including Haupt Pharma, Aristo and Ethypharm. At the same time, Burghard Burczyk has extensive experience as strategic consultant in supply chain and tender business.
Burghard holds a Degree in Mechanical Engineering from the University of Magdeburg, Germany.